SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-007837
Filing Date
2020-11-10
Accepted
2020-11-10 06:01:00
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_111020p.htm 10-Q 728119
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8426
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8410
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5410
5 EXHIBIT 32.2 exh_322.htm EX-32.2 5347
  Complete submission text file 0001171843-20-007837.txt   3587650

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE snca-20200930.xml EX-101.INS 553022
7 XBRL SCHEMA FILE snca-20200930.xsd EX-101.SCH 43658
8 XBRL CALCULATION FILE snca-20200930_cal.xml EX-101.CAL 38403
9 XBRL DEFINITION FILE snca-20200930_def.xml EX-101.DEF 282915
10 XBRL LABEL FILE snca-20200930_lab.xml EX-101.LAB 298418
11 XBRL PRESENTATION FILE snca-20200930_pre.xml EX-101.PRE 305350
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 201299483
SIC: 2836 Biological Products, (No Diagnostic Substances)